JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 32 No. 1 169-173
© 1991 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Culver, C. M.
Right arrow Articles by Dworkin, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Culver, C. M.
Right arrow Articles by Dworkin, H. J.

Radiation Safety Considerations for Post-Iodine-131 Hyperthyroid Therapy

Cheryl M. Culver and Howard J. Dworkin

Nuclear Medicine Department, William Beaumont Hospital, Royal Oak, Michigan

Correspondence: For reprints contact: Cheryl M. Culver, MS, Nuclear Medicine Department, William Beaumont Hospital, 3601 West Thirteen Mile Rd., Royal Oak, MI 48072.

ABSTRACT

The purpose of this study was to develop guidelines based on patient measurements as to when iodine-131- (131I) treated hyperthyroid patients may resume close personal contact. External exposure rates were measured on 59 patients using an ionization survey meter in the upright position. The initial measurement was recorded within 20 min post-dose administration at one meter. Exposure rates were measured 2–11 days post-dose administration at 1, 0.6, and 0.3 meters from the patient's thyroid. In the administered dose range of 3 to less than 12 mCi of 131I, all 40 patients measured ≤ 2.0 mR/hr at one meter on Day 0, and 25 patients (25/29) were ≤2.0 mR/hr at 0.6 meter on Days 2–4. Guidelines can be prepared based on the administered dose that are rational and in conformity with existing radiologic health standards.




This article has been cited by other articles:


Home page
JAMAHome page
P. W. Grigsby, B. A. Siegel, S. Baker, and J. O. Eichling
Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma
JAMA, May 3, 2000; 283(17): 2272 - 2274.
[Abstract] [Full Text] [PDF]


Home page
J Hum LactHome page
L. A. Herman and S. O'Neill
Breastfeeding after Radionuclide Administration
J Hum Lact, September 1, 1995; 11(3): 223 - 227.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1991 by the Society of Nuclear Medicine.